Prevalence and Burden of Bronchiectasis in Tuberculous Patients

Completed

• Conditions: Pulmonary Tuberculoses

• Registration Number: NCT04085133
• Lead Sponsor: Assiut University

Brief Summary

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree

Detailed Description

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree.

The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.\[3\] International data show an increase in the prevalence of bronchiectasis over recent years.

Study Timeline

• Study First Submitted: 2019-05-28
• Status Verified: 2019-09
• Study First Submitted QC: 2019-09-08
• Study First Posted: 2019-09-11
• Study Start: 2019-09-26
• Primary Completion: 2020-01-01
• Study Completion: 2020-04-01
• Last Update Submitted: 2023-02-15
• Last Update Posted: 2023-02-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• 1-patients were diagnosed to have tuberculosis by sputum culture and gene x pert.

  2-patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.

  3- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.

Exclusion Criteria

• 1-patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To study prevalence of bronchiectasis in TB patients by case per year.	One year	How many patients of TB will be diagnosed as abronchiectasis

Secondary Outcome Measures

Name	Time	Method
To evaluate the burden of bronchiectasis in TB patients	one year	by frequency of need for hospital admission per year, need for outpatient clinical visits per month and frequency of need for antimicrobial therapy other than anti-tuberculous treatment per month

Trial Locations

Locations (1)

Assiut unviresty; 🇪🇬 Assiut, Egypt